EDTUTC-4 New YorkLog in Sign up

RGNX
REGENXBIO Inc.
stockNASDAQ

Market OpenOct 5, 2026 1:50:11 PM EDT

7.84USD+5.518%(+0.41)1,283,594

7.8300Bid7.8500Ask0.0200Spread

Pre-marketOct 5, 2026 9:06:30 AM EDT

7.82USD+5.249%(+0.39)

RGNX News

Day breaks

11:37 AM EDTRegenxbio a new Outperform at Mizuho on potential of two pipeline drugs ·

Seeking Alpha

05:10 AM EDTMizuho initiates Regenxbio stock coverage with outperform rating ·

Investing.com

07:50 AM EDTH.C. Wainwright reiterates Regenxbio stock rating on diabetic retinopathy data ·

Investing.com

10:02 AM EDTStifel reiterates Regenxbio stock rating on gene therapy data ·

Investing.com

09:28 AM EDTWhy is Regenxbio stock climbing today? ·

Investing.com

09:07 AM EDTRegenxbio stock gains on positive gene therapy trial data ·

Investing.com

07:17 PM EDTREGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting ·

PR Newswire

01:31 PM EDTREGENXBIO Inc. (RGNX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha

09:20 AM EDTREGENXBIO at Morgan Stanley conference: late-stage gene therapy push ·

Investing.com

09:18 AM EDTREGENXBIO at 2026 Global Healthcare Conference: pipeline, cash runway ·

Investing.com